The Burden Associated with Ocular Symptoms in Allergic Rhinitis

被引:34
作者
Klossek, J. M. [2 ]
Annesi-Maesano, I. [3 ,4 ]
Pribil, C. [5 ]
Didier, A. [1 ]
机构
[1] CHU Toulouse, Hop Larrey, Serv Pneumol Allergol, FR-31059 Toulouse, France
[2] CHU Poitiers, Hop Jean Bernard, Serv ORL, Poitiers, France
[3] Univ Paris 06, INSERM, EPAR, Paris, France
[4] Univ Paris 06, Med Sch St Antoine, Paris, France
[5] GlaxoSmithKline, Marly Le Roi, France
关键词
Allergic rhinitis; Epidemiology; Ocular symptoms; Medical management; OF-LIFE IMPACT; INTRANASAL CORTICOSTEROIDS; EQUALLY CONSISTENT; MEDICAL-PRACTICE; FRANCE; CONJUNCTIVITIS; INTERMITTENT; MANAGEMENT;
D O I
10.1159/000334286
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Ocular symptoms remain widely neglected while they concern the majority of subjects with allergic rhinitis (AR) and impair their daily activities. We describe the characteristics of ocular symptoms in subjects suffering from AR in the French INSTANT study and their impact on daily activities. Methods: This cross-sectional observational survey was carried out in November 2006 using face-to-face interviews. Results: 31.7% of the population-based sample (n = 4,019) suffered from AR and 52.0% of AR subjects (n = 663) described ocular symptoms. Men had significantly less ocular symptoms than women (odds ratio 0.71, 95% CI 0.57-0.89). 57.5% of subjects suffered from ocular symptoms for >5 years, 30.2% for >6 months in the past 12 months, and 92.2% during the pollen season. The troublesome ocular symptoms were itching eyes (51.1%), watery eyes (38.6%), red eyes (6.6%) and swollen eyelids (3.6%). The trigger factors were pollens (51.3%), household dust and mites (34.8%), pets (12.2%) and air pollution (3.8%). Ocular symptoms had a negative impact on daily activities (blurred sight 47.8%, reduction in daily activities 38.8%, reduction in efficacy at work 25.8%, sleep disturbances 16.3%, and sick leave 12.9%). They were diagnosed in 38.9% of subjects and followed up in 34.8%. Treatment for ocular symptoms was prescribed to 35.4% of subjects and to 61.9% of subjects with a regular follow-up care. Conclusions: This survey confirms the impact of ocular symptoms on AR patients' lives and suggests that they are still neglected and undertreated. Copyright (C) 2012 S. Karger AG, Basel
引用
收藏
页码:411 / 417
页数:7
相关论文
共 27 条
[1]   The score for allergic rhinitis (SFAR): a simple and valid assessment method in population studies [J].
Annesi-Maesano, I ;
Didier, A ;
Klossek, M ;
Chanal, I ;
Moreau, D ;
Bousquet, J .
ALLERGY, 2002, 57 (02) :107-114
[2]   Ocular symptom reduction in patients with seasonal allergic rhinitis treated with the intranasal. corticosteroid mometasone furoate [J].
Bielory, Leonard .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2008, 100 (03) :272-279
[3]   Allergic Conjunctivitis and the Impact of Allergic Rhinitis [J].
Bielory, Leonard .
CURRENT ALLERGY AND ASTHMA REPORTS, 2010, 10 (02) :122-134
[4]   Comment on: Are intranasal corticosteroids all equally consistent in managing ocular symptoms of seasonal allergic rhinitis? [J].
Bielory, Leonard .
CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (05) :1139-1140
[5]   Evolving paradigm in the management of allergic rhinitis-associated ocular symptoms: role of intranasal corticosteroids [J].
Blaiss, Michael S. .
CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (03) :821-836
[6]  
Bonini S, 2006, CHEM IMMUNOL ALLERGY, V91, P110
[7]   A survey of the burden of allergic rhinitis in France [J].
Bousquet, J. ;
Scadding, G. K. ;
Williams, A. .
REVUE FRANCAISE D ALLERGOLOGIE ET D IMMUNOLOGIE CLINIQUE, 2008, 48 (05) :382-389
[8]   Characteristics of intermittent and persistent allergic rhinitis:: DREAMS study group [J].
Bousquet, J ;
Annesi-Maesano, I ;
Carat, F ;
Léger, D ;
Rugina, M ;
Pribil, C ;
El Hasnaoui, A ;
Chanal, I .
CLINICAL AND EXPERIMENTAL ALLERGY, 2005, 35 (06) :728-732
[9]   The clinical spectrum of ocular allergy [J].
Brémond-Gignac D. .
Current Allergy and Asthma Reports, 2002, 2 (4) :321-324
[10]   A survey of the burden of allergic rhinitis in Europe [J].
Canonica, G. W. ;
Bousquet, J. ;
Mullol, J. ;
Scadding, G. K. ;
Virchow, J. C. .
ALLERGY, 2007, 62 :17-25